Organic compound, anisotropic optical film and method of production thereof

Abstract

The present invention is related to 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives of the general structural formula (I), the anisotropic optical film based on these derivatives with phase-retarding properties for displays, and method of producing thereof: ##STR00001##
where X is a carboxylic group COOH, m is 0, 1, 2 or 3; Y is a sulfonic group SO.sub.3H, n is 0, 1, 2 or 3; Z is an acid amide group L-NH.sub.2; p is 0, 1, 2 or 3; K is a counterion selected from the list comprising H.sup.+, NH.sub.4.sup.+, Na.sup.+, K.sup.+, Li.sup.+, Mg.sup.2+, Ca.sup.2+, Zn.sup.2+, and Al.sup.3+; s is the number of counterions providing neutral state of the molecule; R is a substituent selected from the list comprising CH.sub.3, C.sub.2H.sub.5, NO.sub.2, Cl, Br, F, CF.sub.3, CN, OH, OCH.sub.3, OC.sub.2H.sub.5, OCOCH.sub.3, OCN, SCN, NH.sub.2, and NHCOCH.sub.3; w is 0, 1, 2, 3 or 4; and R.sub.1 is a substituent selected from the list comprising H, CH.sub.3, C.sub.2H.sub.5, C.sub.3H.sub.7, i-C.sub.3H.sub.7, CH.sub.2CH.sub.2CH.sub.2CH.sub.3, CH(CH.sub.3)CH.sub.2CH.sub.3, CH.sub.2CH(CH.sub.3)CH.sub.3 and C(CH.sub.3).sub.3 and L is a linking group.

Claims

1. A composition comprising a 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivative of structural formula I or a salt thereof: ##STR00034## wherein said derivative does not substantially absorb incident electromagnetic radiation in the visible spectral range.

2. The composition of claim 1, wherein the composition comprises: 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one-9-carboxylic acid, or a salt thereof; 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one-10-carboxylic acid, or a salt thereof; or a mixture of 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one-9-carboxylic acid, or a salt thereof, and 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one-10-carboxylic acid, or a salt thereof.

3. An anisotropic optical film comprising at least one organic layer, wherein the at least one organic layer comprises a 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivative of structural formula I or a salt thereof: ##STR00035## wherein said at least one organic layer does not substantially absorb incident electromagnetic radiation in the visible spectral range.

4. The anisotropic optical film of claim 3, wherein the at least one organic layer is on the front surface of a substrate, wherein the substrate comprises a polymer or glass.

5. The anisotropic optical film of claim 3, wherein said at least one organic layer is substantially insoluble in water or water-miscible solvents.

6. The anisotropic optical film of claim 3, wherein said at least one organic layer contains two or more different 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives of structural formula I.

7. The anisotropic optical film of claim 3, wherein the at least one organic layer comprises a mixture of: 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one-9-carboxylic acid, or a salt thereof; and 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one-10-carboxylic acid, or a salt thereof.

8. The anisotropic optical film of claim 3, wherein the film comprises two or more organic layers containing different 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives of structural formula I, each capable of absorbing electromagnetic radiation in at least one wavelength subrange of the UV spectral range.

9. A method of producing an anisotropic optical film that does not substantially absorb incident electromagnetic radiation in the visible spectral range, said method comprising: (a) depositing on a substrate an aqueous solution comprising a 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivative of formula I or a salt thereof: ##STR00036## and (b) drying said aqueous solution so as to form a solid layer.

10. The method of claim 9, wherein the aqueous solution comprises: 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one-9-carboxylic acid, or a salt thereof; 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one-10-carboxylic acid, or a salt thereof; or a mixture of 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one-9-carboxylic acid, or a salt thereof, and 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one-10-carboxylic acid, or a salt thereof.

11. The method of claim 9, wherein the aqueous solution comprises a mixture of 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one-9-carboxylic acid, or a salt thereof, and 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one-10-carboxylic acid, or a salt thereof.

12. The method of claim 9, wherein said aqueous solution is a lyotropic liquid crystal solution.

13. The method of claim 9, further comprising application of an external alignment action to the aqueous solution prior to the drying step.

14. The method of claim 9, wherein said aqueous solution comprises a water-miscible solvent.

15. The method of claim 9, wherein the substrate is treated prior to the application of said aqueous solution so as to render its surface hydrophilic.

16. The method of claim 9, further comprising treatment of said formed solid layer with a solution of a water-soluble inorganic salt with Ba.sup.2+ cation.

17. The method of claim 9, wherein the sequence of steps (a) and (b) is repeated two or more times and the aqueous solution used in the fabrication of each subsequent solid layer is either the same or different from that used the previous time.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

(1) FIG. 1 shows a viewing direction defined as a set of the polar viewing angle α and the azimuthal viewing angle β.

(2) FIG. 2 shows the refractive indices of an organic layer on a glass substrate prepared from a mixture of 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-9-carboxylic acid and 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-10-carboxylic acid having refractive indices nx=1.631, ny=1.637, and nz=1.844 at a wavelength of 550 nm.

(3) FIG. 3 shows the refractive indices of an organic layer on a glass substrate prepared from a mixture of 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-9-carboxylic acid and 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-10 carboxylic acid having refractive indices nx=1.460, ny=1.840, and nz=1.790 at a wavelength of 550 nm.

(4) FIG. 4 shows a schematic diagram of the cross section of an anisotropic optical film on a substrate, together with additional adhesive and protective layers.

(5) FIG. 5 shows a schematic diagram of the cross section of an anisotropic optical film with an additional antireflection coating.

(6) FIG. 6 shows a schematic diagram of the cross section of an anisotropic optical film with an additional reflective layer.

(7) FIG. 7 shows a schematic diagram of the cross section of an anisotropic optical film with a diffuse or specular reflector as the substrate.

DETAILED DESCRIPTION OF THE INVENTION

(8) The general description of the present invention having been made, a further understanding can be obtained by reference to the specific preferred embodiments, which are given herein only for the purpose of illustration and are not intended to limit the scope of the appended claims.

(9) In its first aspect, the present invention provides 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives of the general structural formula

(10) ##STR00008##
where X is a carboxylic group —COOH, m is 0, 1, 2 or 3; Y is a sulfonic group —SO.sub.3H, n is 0, 1, 2 or 3; Z is an acid amide group -L-NH.sub.2; p is 0, 1, 2 or 3; K is a counterion selected from the list comprising H.sup.+, NH.sub.4.sup.+, Na.sup.+, K.sup.+, Li.sup.+, Mg.sup.2+, Ca.sup.2+, Zn.sup.2+ and Al.sup.3+; s is the number of counterions providing neutral state of the molecule; R is a substituent selected from the list comprising —CH.sub.3, —C.sub.2H.sub.5, —NO.sub.2, —Cl, —Br, —F, —CF.sub.3, —CN, —OH, —OCH.sub.3, —OC.sub.2H.sub.5, —OCOCH.sub.3, —OCN, —SCN, —NH.sub.2, and —NHCOCH.sub.3; w is 0, 1, 2, 3 or 4; R.sub.1 is a substituent selected from the list comprising —H, —CH.sub.3, —C.sub.2H.sub.5, —C.sub.3H.sub.7, —CH(CH.sub.3)CH.sub.3, —CH.sub.2CH.sub.2CH.sub.2CH.sub.3, —CH(CH.sub.3)CH.sub.2CH.sub.3, —CH.sub.2CH(CH.sub.3)CH.sub.3 and —C(CH.sub.3).sub.3; and L is a linking group. The values of at least two of said integers m, n and p are not equal to 0 and said derivative comprises at least two different groups selected from the list comprising X, Y, and Z. Said 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivative does not substantially absorb the incident electromagnetic radiation in the visible spectral range. The number of counterions s may equal zero. In this case the molecule is in the neutral state. The counterion may be selected from the group consisting of H.sup.+, NH.sub.4.sup.+, Na.sup.+, K.sup.+, Li.sup.+, Mg.sup.2+, Ca.sup.2+, Zn.sup.2+ and Al.sup.3+ or from the group consisting of H.sup.+, NH.sub.4.sup.+, Na.sup.+, K.sup.+, and Li.sup.+. L is preferably CO or SO.sub.2. In one preferred embodiment of the disclosed invention, the 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives further ensure the absorption of electromagnetic radiation in at least one predetermined wavelength subrange of the UV spectral range. The molecules of such 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives can absorb electromagnetic radiation only in a part of the UV spectral range, rather than in the entire range, and this part of the UV range will be called subrange. This subrange can be determined experimentally for each particular 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivative. In one preferred embodiment of the disclosed 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives, at least one said acid amide group is carboxyamide CONH.sub.2. In another preferred embodiment of the disclosed 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-ones, at least one said acid amide group is sulfonamide SO.sub.2NH.sub.2. Examples of 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives comprising at least one carboxylic group COOH, wherein the integer m is between 1 and 3 and said derivative has the general structural formula from the group comprising structures 1 to 11, are given in Table 1.

(11) TABLE-US-00001 TABLE 1 Examples of 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives containing carboxylic groups (1) 0 (2) (3) (4) (5) (6) (7) (8) (9) (10) (11)

(12) In another preferred embodiment of the disclosed 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives, said acid group, providing solubility in water, is a sulfonic group. Examples of the 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives comprising sulfonic groups SO.sub.3H, wherein integer n is between 1 and 3 and said derivative has the general structural formula from the list comprising structures 12 to 20, are given in Table 2.

(13) TABLE-US-00002 TABLE 2 Examples of 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives containing sulfonic groups 0 (12) (13) (14) (15) (16) (17) (18) (19) (20)

(14) In one preferred embodiment of the present invention, the derivative comprises one or more carboxylic acid groups and one or more sulfonic groups. In another preferred embodiment of the present invention, the derivative comprises one or more carboxylic acid group and one or more sulfonamide groups. In still another preferred embodiment of the present invention, the derivative comprises one or more carboxylic acid groups and one or more carboxyamide groups. In yet another preferred embodiment of the present invention, the derivative comprises one or more sulfonic acid groups and one or more carboxyamide groups. In a possible preferred embodiment of the present invention, the derivative comprises one or more sulfonic acid groups and one or more sulfonamide groups. In another preferred possible embodiment of the present invention, the derivative comprises one or more sulfonic acid groups and one or more sulfonamide groups and one or more carboxyamide groups. In one preferred embodiment of the present invention, the derivative comprises one or more carboxylic acid groups and one or more sulfonamide groups and one or more carboxyamide groups. In another preferred embodiment of the present invention, the derivative comprises one or more carboxylic acid groups and one or more sulfonic acid groups and one or more carboxyamide groups. In still another preferred embodiment of the present invention, the derivative comprises one or more carboxylic acid groups and one or more sulfonic acid groups and one or more sulfonamide groups. In yet another preferred embodiment of the present invention, the derivative comprises one or more carboxylic acid groups and one or more sulfonic acid groups and one or more sulfonamide groups and one or more carboxyamide groups.

(15) Preferred 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives include: 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one-9-carboxylic acid; 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one-10-carboxylic acid; 2(3)-sulfonamide-6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one-9-carboxylic acid; 2(3)-sulfonamide-6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one-10-carboxylic acid; 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one-9-carboxylic acid amide; 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one-10-carboxylic acid amide; and 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one sulfo-sulfonamides.

(16) In its second aspect, the present invention provides an anisotropic optical film comprising a substrate having the front and rear surfaces and at least one organic layer applied on the front surface of the substrate and comprising at least one 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivative with the general structural formula

(17) ##STR00029##
where X is a carboxylic group —COOH; m is 0, 1, 2 or 3; Y is a sulfonic group —SO.sub.3H; n is 0, 1, 2 or 3; Z is an acid amide group -L-NH.sub.2; p is 0, 1, 2 or 3; K is a counterion selected from the list comprising H.sup.+, NH.sub.4, Na.sup.+, K.sup.+, Li.sup.+, Mg.sup.2+, Ca.sup.2+, Zn.sup.2+, Al.sup.3+ and Ba.sup.2+, s is the number of counterions providing neutral state of the molecule; R is a substituent selected from the list comprising —CH.sub.3, —C.sub.2H.sub.5, —NO.sub.2, —Cl, —Br, —F, —CF.sub.3, —CN, —OH, —OCH.sub.3, —OC.sub.2H.sub.5, —OCOCH.sub.3, —OCN, —SCN, —NH.sub.2, and —NHCOCH.sub.3; w is 0, 1, 2, 3 or 4; R.sub.1 is a substituent selected from the list comprising —H, —CH.sub.3, —C.sub.2H.sub.5, —C.sub.3H.sub.7, —CH(CH.sub.3)CH.sub.3, —CH.sub.2CH.sub.2CH.sub.2CH.sub.3, —CH(CH.sub.3)CH.sub.2CH.sub.3, —CH.sub.2CH(CH.sub.3)CH.sub.3 and —C(CH.sub.3).sub.3; and L is a linking group. The values of at least two of said integers m, n and p are not equal to 0 and said derivative comprises at least two different groups selected from the list comprising X, Y, and Z. Said organic layer does not substantially absorb incident electromagnetic radiation in the visible spectral range. The counterion may be selected from the group consisting of H.sup.+, NH.sub.4.sup.+, Na.sup.+, K.sup.+, Li.sup.+, Mg.sup.2+, Ca.sup.2+, Zn.sup.2+, Ba.sup.2+ and Al.sup.3+ or from the group consisting of H.sup.+, NH.sub.4.sup.+, Na.sup.+, K.sup.+, Li.sup.+, Mg.sup.2+, Ca.sup.2+, Zn.sup.2+, Ba.sup.2+ and Sr.sup.2+. In one preferred embodiment of the disclosed anisotropic optical film, said organic layer absorbs electromagnetic radiation in at least one predetermined spectral subrange of the UV range. Such anisotropic optical films can absorb electromagnetic radiation only in a part of the UV spectral range, rather than in the entire range, and this part of the UV range is called the subrange. This subrange can be determined experimentally for each particular aqueous solution of an 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivative used for the formation of the anisotropic optical film. Similarly, the absorption subrange can be experimentally determined for a mixture of 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives used for the formation of said film. Thus, such experimentally determined absorption subrange electromagnetic radiation can be considered as the predetermined subrange.

(18) In one embodiment of the disclosed anisotropic optical film, said organic layer is substantially insoluble in water and/or in water-miscible solvents. The 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivative used in the anisotropic optical film is preferably as described above with regard to the first aspect of the present invention. Examples of the 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivative comprising at least one carboxylic group COOH and having the general structural formula from the group comprising structures 1 to 11 are given in Table 1 wherein integer m is between 1 and 3. Examples of the 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives comprising at least one said sulfonic groups SO.sub.3H and having the general structural formula from the group comprising structures 12 to 20 are given in Table 2 wherein integer n is between 1 and 3. In an embodiment of the anisotropic optical film, said organic layer contains two or more 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives with the general structural formula I, each ensuring the absorption of electromagnetic radiation in at least one predetermined wavelength subrange of the UV spectral range. In another embodiment of the anisotropic optical film, said 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivative forms supramolecules that are oriented predominantly parallel to the substrate surface.

(19) In another preferred embodiment of the anisotropic optical film according to this invention, said organic layer is a biaxial retardation layer that is characterized by two in-plane refractive indices (nx and ny) and one refractive index (nz) in the normal direction. In general case the refractive indices (nx, ny and nz) of biaxial retardation layer have different values.

(20) In one embodiment of the disclosed anisotropic optical film, the refractive indices nx, ny, and nz meet the following condition: nx<ny<nz. In still another preferred embodiment of the anisotropic optical film, the in-plane refractive indices (nx and ny) and the organic layer thickness d meet the following condition: d.Math.(ny−nx)<20 nm. In one embodiment of the disclosed anisotropic optical film, the in-plane refractive indices (nx and ny) and the organic layer thickness d meet the following condition: d.Math.(ny−nx)<10 nm. In still another embodiment of the disclosed anisotropic optical film, the in-plane refractive indices (nx and ny) and the organic layer thickness d meet the following condition: d.Math.(ny−nx)<5 nm.

(21) In another embodiment of the disclosed anisotropic optical film, the refractive indices nx, ny, and nz meet the following condition: nx<nz<ny. In still another preferred embodiment of the anisotropic optical film, the refractive indices ny and nz and the organic layer thickness d meet the following condition: d.Math.(ny−nz)<20 nm. In one embodiment of the disclosed anisotropic optical film, the refractive indices ny and nz and the organic layer thickness d meet the following condition: d.Math.(ny−nz)<10 nm. In still another embodiment of the disclosed anisotropic optical film, the refractive indices ny and nz and the organic layer thickness d meet the following condition: d.Math.(ny−nz)<5 nm.

(22) It is to be noted that conditions nx<nz<ny are equivalent to nx>nz>ny. A refractive index nx is transformed into a refractive index ny when the Cartesian system of coordinates rotates about a vertical axis (0z-axis) by 90 degrees. Similarly a refractive index ny is transformed into a refractive index nx. In this embodiment, the in-plane refractive indices are not equal among themselves and refractive index in the normal direction has intermediate value between these in-plane refractive indices. This ratio of the refractive indexes disclosed in the invention is invariant relative to a transformation of Cartesian system of coordinates.

(23) In one preferred embodiment of the disclosed anisotropic optical film, the substrate is transparent for electromagnetic radiation in the visible spectral range. In another preferred embodiment of the disclosed anisotropic optical film, said substrate is made of a polymer. In still another preferred embodiment of the disclosed anisotropic optical film, the substrate is made of a glass.

(24) In an embodiment of the disclosed anisotropic optical film, the transmission coefficient of the substrate does not exceed 2% at any wavelength in the UV spectral range. In an embodiment of the disclosed anisotropic optical film, the transmission coefficient of the substrate in the visible spectral range is no less than 90%. In another embodiment of the anisotropic optical film, the rear surface of the substrate is covered with an additional antireflection or antiglare coating. In one preferred embodiment of the disclosed invention, the substrate further comprises a reflective layer that is applied onto the rear surface of the substrate.

(25) In a preferred embodiment of the present invention, the anisotropic optical film further comprises an additional adhesive transparent layer deposited above said reflective layer. In one embodiment of the anisotropic optical film, the substrate is a specular or diffusive reflector. In another embodiment of the anisotropic optical film, the substrate is a reflective polarizer. In still another preferred embodiment, the anisotropic optical film further comprises a planarization layer deposited onto the front surface of the substrate. In yet another preferred embodiment of the invention, the anisotropic optical film further comprises an additional transparent adhesive layer placed on top of the organic layer. In one embodiment of the disclosed invention, the anisotropic optical film further comprises a protective coating formed on the transparent adhesive layer. In one preferred embodiment of the disclosed anisotropic optical film, the transmission coefficient of the adhesive layer does not exceed 2% at any wavelength in the UV spectral range. In another preferred embodiment of the disclosed anisotropic optical film, the transmission coefficient of the adhesive layer in the visible spectral range is no less than 90%. In still another preferred embodiment of the disclosed invention, the anisotropic optical film comprises two or more organic layers, wherein each of these layers contains different 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives with the general structural formula I, ensuring the absorption of electromagnetic radiation in at least one predetermined wavelength subrange of the UV spectral range.

(26) In its third aspect, the present invention provides a method of manufacturing an anisotropic optical film, which comprises the following steps: (a) depositing an aqueous solution of supramolecules, formed from one or more 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives on a substrate, and (b) drying of said aqueous solution of supramolecules to form a solid layer, wherein said 6,7-dihydrobenzimidazo[1,2-quinazolin-6-one derivative has the general structural formula

(27) ##STR00030##

(28) Here, X is a carboxylic group —COOH; m is 0, 1, 2 or 3; Y is a sulfonic group —SO.sub.3H; n is 0, 1, 2 or 3; Z is an acid amide group -L-NH.sub.2; p is 0, 1, 2 or 3; K is a counterion selected from the list comprising H.sup.+, NH.sub.4.sup.+, Na.sup.+, K.sup.+, Li.sup.+, Mg.sup.2+, Ca.sup.2+, Zn.sup.2+ and Al.sup.3+; s is the number of counterions providing neutral state of the molecule; R is a substituent selected from the list comprising —CH.sub.3, —C.sub.2H.sub.5, —NO.sub.2, —Cl, —Br, —F, —CF.sub.3, —CN, —OH, —OCH.sub.3, —OC.sub.2H.sub.5, —OCOCH.sub.3, —OCN, —SCN, —NH.sub.2, and —NHCOCH.sub.3; w is 0, 1, 2, 3 or 4; R.sub.1 is a substituent selected from the list comprising —H, —CH.sub.3, —C.sub.2H.sub.5, —C.sub.3H.sub.7, —CH(CH.sub.3)CH.sub.3, —CH.sub.2CH.sub.2CH.sub.2CH.sub.3, —CH(CH.sub.3)CH.sub.2CH.sub.3, —CH.sub.2CH(CH.sub.3)CH.sub.3 and —C(CH.sub.3).sub.3; and L is a linking group. The values of at least two of said integers m, n and p are not equal to 0 and said derivative comprises at least two different groups selected from the list comprising X, Y, and Z. The counterion may be selected from the group consisting of H.sup.+, NH.sub.4.sup.+, Na.sup.+, K.sup.+, Li.sup.+, Mg.sup.2+, Ca.sup.2+, Zn.sup.2+, and Al.sup.3+ or from the group consisting of H.sup.+, NH.sub.4.sup.+, Na.sup.+, K.sup.+ and Li.sup.+.

(29) In another preferred embodiment of the invention, the method further includes the application of an external alignment action upon the aqueous solution of supramolecules prior to the drying step.

(30) In still another preferred embodiment of the disclosed method, said aqueous solution also ensures the absorption of electromagnetic radiation in at least one predetermined wavelength subrange of the UV spectral range. Such aqueous solutions absorb electromagnetic radiation only in a part of the UV spectral range, rather than in the entire range, and this part of the UV range is called the subrange. This subrange can be determined experimentally for each particular aqueous solution of an 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivative used for the formation of the anisotropic optical film. Similarly, the absorption subrange can be experimentally determined for a mixture of 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives used for the formation of said film. Thus, such experimentally determined absorption subrange electromagnetic radiation can be considered as the predetermined subrange.

(31) The 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivative used in the method of the present invention is preferably as described above with regard to the first aspect of the present invention.

(32) In one embodiment, the acid group, providing solubility in water, is a carboxylic group. Examples of the 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives comprising at least one carboxylic group —COOH and having the general structural formula from the group comprising structures 1 to 11 are given in Table 1, wherein integer m is between 1 and 3. In another embodiment, the acid group, providing solubility in water, is a sulfonic group. Examples of the 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives comprising at least one sulfonic group —SO.sub.3H and having the general structural formula from the group comprising structures 12 to 20 are given in Table 2 wherein said integer n is between 1 and 3.

(33) In one preferred embodiment of the disclosed method, said aqueous solution is based on a water-miscible solvent. In still another preferred embodiment of the disclosed method, the drying step comprises treatment with an airflow. In yet another preferred embodiment of the disclosed method, the drying step is performed with or without an airflow at an elevated temperature of 23 to 60 degrees centigrade. This temperature range reduces recrystallization and exfoliation (or cracking) of the solid layer. In an embodiment of the disclosed method, the substrate is pretreated so as to provide surface hydrophilization before application of said aqueous solution. In another embodiment of the present invention, the disclosed method further includes treatment of the formed solid layer having the sulfonic groups with a solution of a water-soluble inorganic salt with a Ba.sup.2+ cation. In one embodiment of the disclosed method, an aqueous solution of supramolecules has a concentration selected from the range between 1% and 35% to produce the film having the predetermined properties. In one embodiment of the disclosed method, the application of said 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivative solution onto the substrate is accompanied or followed by an external orienting action upon this solution. In yet another preferred embodiment of the disclosed method, the cycle including the technological operations of solution application, alignment action, and drying is repeated two or more times, and sequential solid layers are formed using either the same of different aqueous solutions, which absorb electromagnetic radiation in at least one preset spectral subrange of the UV spectral range.

(34) In one embodiment of the present invention the aqueous solution of supramolecules is a lyotropic liquid crystal solution. In another embodiment of the present invention the aqueous solution of supramolecules is a gel-like solution.

(35) Other objects and advantages of the present invention will become apparent upon reading detailed description of the examples and the appended claims provided below, and upon reference to the drawings.

(36) In order that the invention may be more readily understood, reference is made to the following examples, which are intended to be illustrative of the invention, but are not intended to be limiting in scope. All the abovementioned compounds can be produced by the known ways (sulfonation, sulfochlorination and amidation) from 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one and its carboxylic acids. Besides they can be synthesized by the direct condensation of isatin and o-phenylenediamine substituted with appropriate substituents.

EXAMPLES

Example 1

(37) This example describes the synthesis of a mixture of 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-9-carboxylic acid and 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-10-carboxylic acid

(38) The first stage is the synthesis of the mixture of 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-9-carboxylic acid and 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-10-carboxylic acid. [0068]3,4-Diaminobenzoic acid (5.0 g) is dissolved in the mixture of water and hydrochloric acid (84.0 g of water and 3.4 g of 35%-solution of HCl) at 20° C. Isatin (4.8 g) is mixed with 70.0 g of glacial acetic acid and 30.0 g of water. The solution of 3,4-diaminobenzoic acid is added to the suspension of isatin and the resulting mixture is stirred for 5 min. Then peroxyacetic acid (6.4 g of 39%) is added. The reaction temperature is raised to 50° C. and the reactive mass is kept at this temperature for 20 min, whereupon the temperature is reduced to ambient temperature. Resulting suspension is filtered, the filter cake is washed with diluted acetic acid (50 ml of acetic acid in 100 ml of water). The precipitate is air dried for 15 hours at 100° C. The process yielded 6.6 g of the mixture of 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-9-carboxylic acid and 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-10-carboxylic acid.

(39) The mass spectrum of the product recorded using a Vision 2000 spectrometer is as follows: m/z, 279.3; mol. wt., 279.06. .sup.1H NMR (Bruker WM-250, DMSO-d.sub.6, δ ppm): 7.39 (q, 2H, 8 Hz); 7.68 (t, 1H, 6 Hz); 7.88 (d, 2H); 8.09 (d, 1H); 8.32 (d, 1H); 8.95 (s, 1H); (isomers mixture). The electronic absorption spectrum of an aqueous solution of the product measured using an Ocean PC 2000 UV/VIS spectrophotometer showed the absorption maxima at λ.sub.max1=325 nm and λ.sub.max2=335-340 nm. The elemental analyses gave the following results (%): C, 64. 52; H, 3. 25; N, 15.05; (anal. calcd. for C.sub.15H.sub.9N.sub.3O.sub.3); C, 64. 71; H, 3. 13; N, 15.00 (found).

(40) Finally, this example describes the synthesis of the mixture of 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-9-carboxylic acid and 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-10 carboxylic acid. A mixture of sulfo-carboxylic acids of 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one is synthesized by sulfonation of the mixture of 9- and 10-carboxylic acids of 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one. Mixture of 9- and 10-carboxylic acids of 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one (5.0 g) is added to 50 ml of 20% oleum and stirred for 1 h at room temperature. The reaction mass is diluted with water (85 ml). The evolved precipitate is filtered and washed with diluted HCl by slurrying (150 ml of 1% HCl×4) and filtered. The precipitate is air dried at 120° C. The process yielded 4.0 g of the mixture of 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-9-carboxylic acid and 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-10-carboxylic acid.

(41) The mass spectrum of the product recorded using a Vision 2000 spectrometer is as follows: m/z, 359.4; mol. wt., 359.02. The electronic absorption spectrum of an aqueous solution of the product measured using an Ocean PC 2000 UV/VIS spectrophotometer showed the absorption maxima at λ.sub.max1=325 nm and λ.sub.max2=335-340 nm. The elemental analyses gave the following results (%): C, 50.14; H, 2.52; N, 11.69; S, 8.92; (anal. calcd. for C.sub.15H.sub.9N.sub.3O.sub.6S); C, 50.44; H, 2.54; N, 11.87 (found).

Example 2

(42) This example describes the synthesis of a mixture of sulfonamide-carboxylic acids of 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one, which is performed according to the following scheme:

(43) ##STR00031##

(44) A mixture of 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-9-carboxylic acid and 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-10-carboxylic acid (5.0 g) is stirred with chlorosulfonic acid (50 ml) at 95° C. for 4 hour. Then, the reaction mass is poured into ice (150 g). The precipitate is separated by filtration and washed with ice-cold water (100 ml) until neutral reaction of the wash water. According to HPLC data, the residue on the filter contained 91.5% of the target product and 5% of a carboxysulfonic acid derivative.

(45) This residue is introduced by small portions into aqueous ammonia solution (50 ml), and the mixture is stirred for about one hour at room temperature. Then, the ammonia solution is acidified to pH 2.5 by adding sulfuric acid. The precipitate is filtered, suspended in 3% hydrochloric acid (100 ml), and filtered again. The residue is washed with water (60 ml). This procedure yielded 3.9 g of 2(3)-sulfonamide-6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-9-carboxylic acid and 2(3)-sulfonamide-6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-10-carboxylic acid mixture (the product comprises 87% of the target compound and 5% of a carboxysulfonic acid derivative). The precipitate is air dried at 105° C.

(46) The mass spectrum of the product recorded using a Vision 2000 spectrometer is as follows: m/z, 358.6; mol. wt., 358.04. The electronic absorption spectrum of an aqueous solution of the product measured using an Ocean PC 2000 UV/VIS spectrophotometer showed the absorption maxima at λ.sub.max1=325 nm and λ.sub.max2=335-340 nm. The elemental analyses gave the following results (%): C, 50.28; H, 2.81; N, 15.64; S, 8.95 (anal. calcd. for C.sub.15H.sub.10N.sub.4O.sub.5S); C, 50.63; H, 2.88; N, 16.01 (found).

Example 3

(47) This example describes the synthesis of a mixture of 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-9-carboxylic acid amide and 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-10-carboxylic acid amide.

(48) At first, this example describes the synthesis of a mixture of 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-9-carboxylic acid amide and 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-10-carboxylic acid amide, which is performed according to the following scheme:

(49) ##STR00032##

(50) A mixture of 9-carboxy-6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one (6 g) with thionyl chloride (60 ml) is boiled for 2.5 hours. The final reaction mixture is filtered, and the residue is washed with carbon tetrachloride (50 ml). After vacuum drying, the precipitate is gradually introduced into aqueous ammonia solution (90 ml) with cooling on ice-cold water bath, so that the temperature of the reaction mixture is kept around 5° C. The obtained suspension is stirred for 30 min at the indicated temperature and then heated to 45° C. and stirred at this temperature for 30 min. The precipitate is filtered hot and washed with water (130 ml). The precipitate is air dried at 105° C. This procedure yielded 4.3 g of mixture of 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-9-carboxylic acid amide and 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-10-carboxylic acid amide (the target compound content according to HPLC is 96.0%).

(51) The mass spectrum of the product recorded using a Vision 2000 spectrometer is as follows: m/z, 278.2; mol. wt., 278.08. The electronic absorption spectrum of an aqueous solution of the product measured using an Ocean PC 2000 UV/VIS spectrophotometer showed the absorption maxima at λ.sub.max1=245-250 nm and λ.sub.max2=335-340 nm. The elemental analyses gave the following results (%): C, 64.74; H, 3.62; N, 20.13; (anal. calcd. for C.sub.15H.sub.10N.sub.4O.sub.2); C, 64.53; H, 3.86; N, 20.01 (found).

(52) Finally, this example describes the synthesis of a mixture of 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-9-carboxylic acid amide and 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-10-carboxylic acid amide.

(53) A mixture of 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-9-carboxylic acid amide and 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-10-carboxylic acid amide (4.0 g) is stirred with 20% oleum (40 ml) for 1 hour at room temperature. The reaction mass is diluted with water (68 ml) and the precipitate is separated by filtration and washed twice at slurrying with 3% hydrochloric acid (150 ml×2). The precipitate is air dried at 100° C. The procedure yielded 4.2 g of mixture of 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-9-carboxylic acid amide and 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-10-carboxylic acid amide.

(54) The mass spectrum of the product recorded using a Vision 2000 UV/VIS spectrometer (negative ion reflection mode) is as follows: m/z, 358.6; mol. wt., 358.04. The electronic absorption spectrum of an aqueous solution of the product measured using an Ocean PC 2000 UV/VIS spectrophotometer showed the absorption maxima at λ.sub.max1=325 nm and λ.sub.max2=335-340 nm. The elemental analyses gave the following results (%): C, 50.28; H, 2.81; N, 15.64; (anal. calcd. for C.sub.15H.sub.10N.sub.4O.sub.5S); C, 49.94; H, 2.93; N, 16.00 (found).

Example 4

(55) This example describes the synthesis of a mixture of sulfonamide-sulfonic acids of 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one, which is performed according to the following scheme:

(56) ##STR00033##

(57) The first stage is the synthesis of a mixture of sulfonamide-sulfonic acids of 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one. To this end, a mixture of 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one (3 g) and chlorosulfonic acid (18 ml) is stirred for 2 hours at 45-50° C. The reaction mass is poured into ice (100 g). The precipitate is separated by filtration and washed on the filter with ice-cold water (100 ml) until neutral reaction of the wash water. This precipitate is introduced into aqueous ammonia solution (60 ml) and stirred for 30 min at room temperature and then for 30 min at 40° C. Then, the solution is filtered from insoluble contaminations and acidified to pH 6.7 with hydrochloric acid. The precipitate is separated by filtration and washed with water (120 ml). The yield of the intermediate sulfonamide mixture is 2.1 g.

(58) Sulfonation of the obtained mixture of 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one sulfonamides is carried out as follows. 6,7-Dihydrobenzimidazo[1,2-c]quinazolin-6-one sulfonamides (2 g) were introduced into 20% oleum (12 ml) and the mixture is stirred for one hour at room temperature. The reaction mass is diluted with water (22 ml). The precipitate is filtered and washed twice at slurrying with diluted HCl (30 ml of 3% HCl). Finally, the product is dried in vacuum. This procedure yielded 2 g of the mixture of 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one sulfo-sulfonamides.

(59) The mass spectrum of the product recorded using a Vision 2000 spectrometer is as follows: m/z, 394.4; mol. wt., 394.00. The electronic absorption spectrum of an aqueous solution of the product measured using an Ocean PC 2000 UV/VIS spectrophotometer showed the absorption maxima at λ.sub.max1=325 nm and λ.sub.max2=335-340 nm. The elemental analyses gave the following results (%): C, 42.64; H, 2.56; N, 14.21; (anal. calcd. for C.sub.14H.sub.10N.sub.4O.sub.6S.sub.2); C, 42.45; H, 2.93; N, 14.44 (found).

Example 5

(60) This example describes the preparation of an organic layer from a lyotropic liquid crystal solution. A mixture of 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-9-carboxylic acid and 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-10-carboxylic acid (2g) obtained as described in Example 1 is further stirred for 1 hour at a temperature of 20° C. in a mixture of 9.0 ml of deionised water with 2.0 ml of a 10% aqueous ammonia solution until a lyotropic liquid crystal solution is formed. At temperature of 20° C. and relative humidity of 65% the obtained solution is applied onto a pretreated glass plate surface with a Mayer rod #2.5 moved at a linear velocity of 15 mm/s and dries. In order to determine the optical characteristics of the organic layer, the optical transmission spectrum was measured in a wavelength range from 400 to 700 nm using a Cary 500 spectrophotometer. The optical transmission of the organic layer is measured using the light beams linearly polarized parallel and perpendicular to the coating direction (T.sub.par and T.sub.per, respectively). The obtained data were used to calculate the refractive indices (nx, ny, and nz) presented in FIG. 2. The obtained organic layer has refractive indices nx=1.631, ny=1.637, and nz=1.844 at 550 nm wavelength. The measurements showed essentially small values of the absorption coefficients of the organic layer.

Example 6

(61) This example describes the preparation of an organic layer from a lyotropic liquid crystal solution. A mixture of 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-9-carboxylic acid and 2(3)-sulfo-6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one-10 carboxylic acid (2g) obtained as described in Example 1 is stirred for 1 hour at a temperature of 20° C. in a mixture of 9.0 ml of deionised water with 2.0 ml of a 10% aqueous ammonia solution until a lyotropic liquid crystal solution is formed. At temperature of 20° C. and relative humidity of 65% the obtained solution is applied onto a pre-treated glass plate surface with a Mayer rod #2.5 moved at a linear velocity of 15 mm/s and is dried after that. In order to determine the optical characteristics of the organic layer, the optical transmission spectrum is measured in a wavelength range from 400 to 700 nm using a Cary 500 spectrophotometer. The optical transmission of the organic layer is measured using the light beams linearly polarized parallel and perpendicular to the coating direction—T.sub.par and T.sub.per, respectively. The obtained data were used to calculate the refractive indices (nx, ny, and nz) presented in FIG. 3. The obtained organic layer has refractive indices nx=1.460, ny=1.840, and nz=1.790 at 550 nm wavelength. The measurements showed essentially small values of the absorption coefficients of the organic layer.

Example 7

(62) FIG. 4 shows the cross section of anisotropic an optical film formed on substrate 7. The film comprises organic layer 8, adhesive layer 9, and protective layer 10. Substrate 7 is made of poly(ethylene terephthalate) (PET) (e.g., Toray QT34/QT10/QT40, or Hostaphan 4607, or Dupont Teijin Film MT582). The substrate has a thickness from 30 to 120 μm and a refractive index of n=1.5 (Toray QT10), 1.7 (Hostaphan 4607), 1.51 (Dupont Teijin Film MT582). The organic layer can be manufactured using the methods described in Example 6. The polymer layer 10 protects the anisotropic optical film from damage in the course of its transportation. This anisotropic optical film is a semiproduct, which can be used as an external retarder, for example, in LCDs. Upon the removal of protective layer 10, the remaining film is applied onto an LCD glass with adhesive layer 9.

Example 8

(63) An anisotropic optical film with an organic layer 11 (FIG. 5) and otherwise identical to the film described above can be applied to the LCD front surface. For example, an antireflection layer of silicon dioxide (SiO.sub.2) reduces by 30% the fraction of light reflected from the LCD front surface.

Example 9

(64) With the above described anisotropic optical film applied to the front surface of an electrooptical device or an LCD, an additional reflective layer 12 can be formed on the rear substrate surface (FIG. 6). The reflective layer can be obtained, for example, by depositing an aluminium film.

Example 10

(65) FIG. 7 shows the organic layer 8 is applied onto the diffuse or specular semitransparent reflector 12 that serves as a substrate (FIG. 7). The reflector layer 12 may be also covered with planarization layer 13 (optional), which can be made of polyurethane, an acrylic polymer, or any other material. The substrate 12 can be made of PET (e.g., Toray QT34/QT10/QT40, Hostaphan 4607, or Dupont Teijin Film MT582). The substrate thickness is 30 to 120 μm and a refractive index is n=1.5 (Toray QT10), 1.7 (Hostaphan 4607), 1.51 (Dupont Teijin Film MT582). The organic layer can be manufactured using the method described in Example 6. The adhesive layer 9 and the protective layer 10 are applied on top of the organic layer.

Example 11

(66) This example describes the preparation of an organic layer from a gel-like aqueous solution of supramolecules. A mixture of sulfo-carboxy derivative of 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one (1.3 g) obtained as described in Example 1 is stirred for 1 hour at temperature of 40° C. in a mixture of 22.0 ml of deionised water with 1.0 g of anhydrous Zinc oxide plus 2.0 ml of a 10% aqueous sodium hydroxide until a clear solution is formed. The pH of obtained solution (Solution 1) is adjusted by additional amount of 1% aqueous Sodium hydroxide solution. pH level of Solution 1 is set to pH=4.96 value and let sit overnight. After approximately 20 hours, Solution 1 is set to pH level 7.0 by adding a few drops of 1% aqueous Sodium hydroxide solution with simultaneous mixing with use of a magnetic stirrer with a pH-meter electrode immersed into liquid. The obtained solution (Solution 2) is concentrated on a rotary evaporator until concentration of sulfo-carboxy derivative of 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one equal to 7% (w/w %) is reached. At temperature of 20° C. and a relative humidity of 65% the obtained solution (Solution 3) is applied onto a pretreated glass plate surface with a Mayer rod #4 moved at a linear velocity of 10 mm/s, and then is dried in an airflow. In order to determine the optical characteristics of the organic layer, the optical transmission spectrum is measured in a wavelength range from 400 to 700 nm using a Cary 500 spectrophotometer. The optical transmission of the organic layer is measured using the light beams linearly polarized parallel and perpendicular to the coating direction—T.sub.par and T.sub.per, respectively. The obtained data were used to calculate the refractive indices (nx, ny, and nz). The obtained organic layer has refractive indices nx=1.495, ny=1.839, and nz=1.841 at a wavelength of 550 nm. The measurements showed essentially small values of the absorption coefficients of the organic layer.

Example 12

(67) This example describes the preparation an organic layer from a gel-like aqueous solution of supramolecules. A mixture of sulfo-carboxy derivative of 6,7-dihydrobenzimidazo[1,2-c]quinazoline-6-one (1 g) obtained as described in Example 1 is stirred for 1 hour at temperature of 40° C. in a mixture of 39.0 ml of deionised water with 0.3 g of anhydrous Aluminium chloride plus 2.0 ml of a 10% aqueous sodium hydroxide until a clear solution is formed. The pH of the obtained solution (Solution 1) is controlled by an additional amount of 1% water Sodium hydroxide solution. After 1 hour of mixing, Solution 1 is set to pH level 6.54 by means of adding few drops of 1% aqueous Sodium hydroxide solution while mixed on a magnetic stirrer with a pH-meter electrode immersed into liquid. At temperature of 20° C. and relative humidity of 65% the obtained solution (Solution 2) is applied onto a pretreated glass plate surface with a Mayer rod #4 moved at a linear velocity of 10 mm/s, and is then dried in an airflow. In order to determine the optical characteristics of the organic layer, the optical transmission spectrum is measured in a wavelength range from 400 to 700 nm using a Cary 500 spectrophotometer. The optical transmission of the organic layer is measured using the light beams linearly polarized parallel and perpendicular to the coating direction—T.sub.par and T.sub.per, respectively. The obtained data were used to calculate the refractive indices (nx, ny, and nz). The obtained organic layer has refractive indices nx=1.495, ny=1.655, and nz=1.660 at a wavelength of 550 nm. The measurements showed essentially small values of the absorption coefficients of the organic layer.